DOH adds Molnupiravir in the Updated SRP List
Conduct of the 2022 Antimicrobial Stewardship (AMS) Blended Learning Framework Program for Hospitals through Online Platforms
The DOH Pharmaceutical Division continues to cascade the National Antimicrobial Stewardship (AMS) training program for hospitals through the blended learning framework
DOH Lauds New Price Caps on Medicines
The Department of Health expressed elation over the signing of Executive Order (EO) No. 155, by President Rodrigo Roa Duterte adding 34 medicines to the list of drugs with mandatory price caps.
Adjustments in Maximum Retail Price (MRP) Regulation of Certain Medicines that are Covered by Executive Order No. 155 Pursuant to Exemption from Value Added Tax (VAT)
DOH informs the public of the adjustments in the Maximum Retail Price (MRP) of certain medicines that are covered by EO 155
2021 Progress Report on the implementation of the Cheaper Medicines Act
The DOH shares the progress of initiatives in making medicines affordable and accessible to Filipinos through the implementation of the Cheaper Medicines Act.
Access the full report here
Rational Use of Antimicrobial Agents and Investigational Drugs for the Management of COVID-19
The DOH reiterates the rational use of antimicrobials and investigational drugs for COVID-19 management